Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Fullarton

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Intestinal Research|October 11, 2018
IBD2020 global forum: results of an international patient survey on quality of carePeter Irving, Johan Burisch, Richard Driscoll, et al.
Journal of Medical Economics|April 17, 2023
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infantsBarry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 23, 2014
Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?Xavier Carbonell-Estrany, John R Fullarton, Barry S Rodgers-Gray, et al.
Journal of Medical Economics|February 28, 2025
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in CanadaÉlisabeth Mercier, John R Fullarton, Bosco A Paes, et al.
Respiratory Research|December 10, 2008
A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP StudyEric A F Simões, Xavier Carbonell-Estrany, John R Fullarton, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|February 6, 2013
Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
Annals of Gastroenterology|September 4, 2020
The use of 5-aminosalicylates in Crohn's disease: a retrospective study using the UK Clinical Practice Research DatalinkAilsa Hart, Siew C Ng, John Watkins, et al.
Acta Paediatrica (Oslo, Norway : 1992)|January 18, 2018
Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])Xavier Carbonell-Estrany, Alberto Dall'Agnola, John R Fullarton, et al.
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 12, 2016
The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Intestinal Research|October 11, 2018
IBD2020 global forum: results of an international patient survey on quality of carePeter Irving, Johan Burisch, Richard Driscoll, et al.
Journal of Medical Economics|April 17, 2023
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infantsBarry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 23, 2014
Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?Xavier Carbonell-Estrany, John R Fullarton, Barry S Rodgers-Gray, et al.
Journal of Medical Economics|February 28, 2025
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in CanadaÉlisabeth Mercier, John R Fullarton, Bosco A Paes, et al.
Respiratory Research|December 10, 2008
A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP StudyEric A F Simões, Xavier Carbonell-Estrany, John R Fullarton, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|February 6, 2013
Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
Annals of Gastroenterology|September 4, 2020
The use of 5-aminosalicylates in Crohn's disease: a retrospective study using the UK Clinical Practice Research DatalinkAilsa Hart, Siew C Ng, John Watkins, et al.
Acta Paediatrica (Oslo, Norway : 1992)|January 18, 2018
Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])Xavier Carbonell-Estrany, Alberto Dall'Agnola, John R Fullarton, et al.
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 12, 2016
The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysisXavier Carbonell-Estrany, John R Fullarton, Katherine L Gooch, et al.
Pageof 3